Oreticyl 25

   
Google
 
Web NewDrugInformation.com

Oreticyl 25


Drug - Oreticyl 25
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Deserpidine; Hydrochlorothiazide
Multiple ingredients are in alphabetical order.

Strength - 0.125MG;25MG
The potency of the active ingredient(s), Deserpidine; Hydrochlorothiazide. May repeat for multiple part products.

Applicant - ABBOTT
The firm name holding legal responsibility for Oreticyl 25. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012148
The FDA assigned number to Oreticyl 25. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Oreticyl 25. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Oreticyl 25 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Oreticyl 25. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Oreticyl 25 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of Oreticyl 25.

Oreticyl 25